XIME Bangalore PGDM Admissions 2026
ApplyAccredited by AICTE & NBA | Highest CTC 14.7 LPA | Average CTC 10.5 LPA | Key Recruiters: EY, Deloitte, KPMG, HCL
Accredited by AICTE & NBA | Highest CTC 14.7 LPA | Average CTC 10.5 LPA | Key Recruiters: EY, Deloitte, KPMG, HCL
Application deadline: 4th Dec | Globally Recognized by AACSB (US) & AMBA (UK) | 17.8 LPA Avg. CTC for PGPM 2025
IBSAT 2025-Your gateway to MBA/PGPM @ IBS Hyderabad and 8 other IBS campuses | Scholarships worth 10 CR
Ranked among top 10 B-Schools in India by multiple publications | Top Recruiters-Google, MicKinsey, Amazon, BCG & many more.
'A+ +'NAAC accreditation| AICTE accreditation -Attracts Illustrious In-House and Visiting Faculty
MICAT-2 Applications Closing on 29th Jan’26 | Ranked #33 by NIRF | Highest CTC 40.91 LPA & Average CTC 19.22 LPA
Nova College of Business Management Nuzvid courses provided to the students are at postgraduate levels. Nova College of Business Management Nuzvid courses are offered for two years. Nova College of Business Management Nuzvid is approved by AICTE New Delhi and is affiliated with JNTUK ( Jawaharlal Nehru Technological University, Kakinada).
Nova College of Business Management Nuzvid offers courses in a full-time mode. Candidates must meet the Nova College of Business Management Nuzvid eligibility criteria for pursuing their desired courses. The Nova College of Business Management Nuzvid fees depend on the course chosen by the candidates.
Also see: Nova College of Business Management Nuzvid Admissions
Candidates who are interested in applying for the college should meet the eligibility criteria of the course, and follow the Nova College of Business Management Nuzvid fees structure. The details of the courses offered with their eligibility criteria are mentioned in the table below:
| Course | Eligibility Criteria |
|---|---|
Bachelor's degree with at least 45% marks from a recognised university. |
Candidates must meet the specified eligibility criteria for pursuing courses at the Nova College of Business Management Nuzvid.